Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs
- PMID: 781132
Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs
Abstract
Experimental cutaneous Candida albicans infections were produced in guinea pigs either by using occlusive dressings over the organisms or by applying them to the shaved skin directly without occlusive dressings. In either model there was clearance of the infecting organisms from the skin by a process involving profuse scaling of the keratinized layer in which they were confined. However, for each type of infection the mechanisms producing this scaling seemed to involve different parts of the host defense system. Infections produced under occlusive dressings were characterized by a rapid accumulation of polymorphonuclear leukocytes (PMN) in the epidermis and formation of thick crusts in which organisms were trapped. Sloughing of the crust removed the organisms. In this model, evolution of the lesions and the rate of clearance of the organisms did not depend on prior immunity to Candida. Two possible mechanisms for attraction of PMN into the lesions were direct activation of the alternative complement pathway by the organisms in the lesions and direct chemotactic activity in components of Candida albicans. In contrast, infections produced without occlusive dressings showed only minimal epidermal PMN infiltration, but also underwent profuse scaling of the keratinized layer. This response appeared to depend on cell-mediated immunity. Only animals with previously-acquired delayed hypersensitivity to Candida antigens could undergo this type of scaling, and indeed, this response was transferable to nonimmue animals with peritoneal exudate cells from Candida-immune animals. Clearance of the infecting organisms from this type of infection was significantly faster in immune than in nonimmune animals. It is postulated that a lymphokine released from lymphocytes in the upper epidermis acts on epidermal cells to increase the rate of keratin turnover either by the mitotic rate of the germinal cells or by increasing their rate of keratinization.
Similar articles
-
Participation of neutrophils and delayed hypersensitivity in the clearance of experimental cutaneous candidiasis in mice.Am J Pathol. 1986 May;123(2):241-9. Am J Pathol. 1986. PMID: 3518475 Free PMC article.
-
Study of possible mechanisms of basophil accumulation in experimental cutaneous candidiasis in guinea pigs.J Allergy Clin Immunol. 1977 Feb;59(2):171-7. doi: 10.1016/0091-6749(77)90221-4. J Allergy Clin Immunol. 1977. PMID: 833382
-
Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice.J Lab Clin Med. 1993 Feb;121(2):235-43. J Lab Clin Med. 1993. PMID: 8433039
-
Immunomodulation in response to Candida.Immunol Ser. 1989;47:293-317. Immunol Ser. 1989. PMID: 2490080 Review.
-
Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans.Mol Immunol. 2013 Dec 15;56(3):161-9. doi: 10.1016/j.molimm.2013.05.218. Epub 2013 Jun 26. Mol Immunol. 2013. PMID: 23809232 Review.
Cited by
-
Animal models: an important tool in mycology.Med Mycol. 2007 Dec;45(8):657-84. doi: 10.1080/13693780701644140. Med Mycol. 2007. PMID: 18027253 Free PMC article. Review.
-
Immunity to Candida albicans.Microbiol Rev. 1980 Dec;44(4):660-82. doi: 10.1128/mr.44.4.660-682.1980. Microbiol Rev. 1980. PMID: 7010113 Free PMC article. No abstract available.
-
Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes.Infect Immun. 1993 Nov;61(11):4560-8. doi: 10.1128/iai.61.11.4560-4568.1993. Infect Immun. 1993. PMID: 8406852 Free PMC article.
-
Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.Infect Immun. 1980 Jan;27(1):140-9. doi: 10.1128/iai.27.1.140-149.1980. Infect Immun. 1980. PMID: 6987165 Free PMC article.
-
Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.Infect Immun. 1988 Dec;56(12):3162-6. doi: 10.1128/iai.56.12.3162-3166.1988. Infect Immun. 1988. PMID: 3182076 Free PMC article.